カテゴリ： 世界, 医療/バイオ, QYResearch

注射用アザシチジンの世界市場2023年：先発医薬品、ジェネリック医薬品

■ 英語タイトル：Global Azacitidine for Injection Market Research Report 2023

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA8686）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA8686
■ 発行日：2023年3月
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：95
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥440,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥661,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥881,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[注射用アザシチジンの世界市場2023年：先発医薬品、ジェネリック医薬品]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

本調査資料は注射用アザシチジンのグローバル市場について調査・分析し、世界の注射用アザシチジン市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（先発医薬品、ジェネリック医薬品）、用途別セグメント分析（病院、診療所、その他）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、Celgene、Meitheal Pharmaceuticals、Lupin Limited、Cipla、TEVA、Viatris、Dr. Reddy's Laboratories、Amneal Pharmaceuticals、Natco Pharma、Accord Healthcare、Shilpa Medicare、Chia Tai Tianqing Pharmaceutical、Jiangsu Hansoh Pharmaceutical、Sichuan Huiyu Pharmaceuticalなどが含まれています。注射用アザシチジンのグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。新型コロナとロシア・ウクライナ戦争の影響は、注射用アザシチジン市場規模を算出する際に考慮しました。

・注射用アザシチジン市場の概要
- 製品の定義
- 注射用アザシチジンの種類別セグメント
- 世界の注射用アザシチジン市場規模：タイプ別分析（先発医薬品、ジェネリック医薬品）
- 注射用アザシチジンの用途別セグメント
- 世界の注射用アザシチジン市場規模：用途別分析（病院、診療所、その他）
- 世界の注射用アザシチジン市場規模予測（2018年-2029年）
- 注射用アザシチジンの平均価格推移（2018年-2029年）
- 前提条件と制限事項

・メーカー別競争状況
- メーカー別市場シェア
- 世界の主要メーカー、業界ランキング分析
- メーカー別平均価格
- 注射用アザシチジン市場の競争状況およびトレンド

・注射用アザシチジンの地域別市場規模
- 北米の注射用アザシチジン市場規模（2018年-2029年）
- 米国の注射用アザシチジン市場規模（2018年-2029年）
- ヨーロッパの注射用アザシチジン市場規模（2018年-2029年）
- アジア太平洋の注射用アザシチジン市場規模（2018年-2029年）
- 中国の注射用アザシチジン市場規模（2018年-2029年）
- 日本の注射用アザシチジン市場規模（2018年-2029年）
- 韓国の注射用アザシチジン市場規模（2018年-2029年）
- インドの注射用アザシチジン市場規模（2018年-2029年）
- オーストラリアの注射用アザシチジン市場規模（2018年-2029年）
- 中南米の注射用アザシチジン市場規模（2018年-2029年）
- 中東・アフリカの注射用アザシチジン市場規模（2018年-2029年）

・種類別セグメント：先発医薬品、ジェネリック医薬品
- 世界の注射用アザシチジンのタイプ別販売量（2018年-2023年）
- 世界の注射用アザシチジンのタイプ別売上（2018年-2023年）
- 世界の注射用アザシチジンのタイプ別価格

・用途別セグメント：病院、診療所、その他
- 世界の注射用アザシチジンの用途別販売量（2018年-2023年）
- 世界の注射用アザシチジンの用途別売上（2018年-2023年）
- 世界の注射用アザシチジンの用途別価格

・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向
Celgene、Meitheal Pharmaceuticals、Lupin Limited、Cipla、TEVA、Viatris、Dr. Reddy's Laboratories、Amneal Pharmaceuticals、Natco Pharma、Accord Healthcare、Shilpa Medicare、Chia Tai Tianqing Pharmaceutical、Jiangsu Hansoh Pharmaceutical、Sichuan Huiyu Pharmaceutical

・産業チェーンと販売チャネルの分析
- 注射用アザシチジン産業チェーン分析
- 注射用アザシチジンの主要原材料
- 注射用アザシチジンの販売チャネル
- 注射用アザシチジンのディストリビューター
- 注射用アザシチジンの主要顧客

・注射用アザシチジン市場ダイナミクス
- 注射用アザシチジンの業界動向
- 注射用アザシチジン市場の成長ドライバ、課題、阻害要因

・調査の結論

・調査手法と情報源

Highlights
The global Azacitidine for Injection market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Azacitidine for Injection is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Azacitidine for Injection is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Azacitidine for Injection include Celgene, Meitheal Pharmaceuticals, Lupin Limited, Cipla, TEVA, Viatris, Dr. Reddy’s Laboratories, Amneal Pharmaceuticals and Natco Pharma, etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Azacitidine for Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Azacitidine for Injection.
The Azacitidine for Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Azacitidine for Injection market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Azacitidine for Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Celgene
Meitheal Pharmaceuticals
Lupin Limited
Cipla
TEVA
Viatris
Dr. Reddy’s Laboratories
Amneal Pharmaceuticals
Natco Pharma
Accord Healthcare
Shilpa Medicare
Chia Tai Tianqing Pharmaceutical
Jiangsu Hansoh Pharmaceutical
Sichuan Huiyu Pharmaceutical
Segment by Type
Original Drug
Generic Drug
Segment by Application
Hospitals
Clinics
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Azacitidine for Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Azacitidine for Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Azacitidine for Injection Market Overview
1.1 Product Overview and Scope of Azacitidine for Injection
1.2 Azacitidine for Injection Segment by Type
1.2.1 Global Azacitidine for Injection Market Value Comparison by Type (2023-2029)
1.2.2 Original Drug
1.2.3 Generic Drug
1.3 Azacitidine for Injection Segment by Application
1.3.1 Global Azacitidine for Injection Market Value by Application: (2023-2029)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Azacitidine for Injection Market Size Estimates and Forecasts
1.4.1 Global Azacitidine for Injection Revenue 2018-2029
1.4.2 Global Azacitidine for Injection Sales 2018-2029
1.4.3 Global Azacitidine for Injection Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Azacitidine for Injection Market Competition by Manufacturers
2.1 Global Azacitidine for Injection Sales Market Share by Manufacturers (2018-2023)
2.2 Global Azacitidine for Injection Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Azacitidine for Injection Average Price by Manufacturers (2018-2023)
2.4 Global Azacitidine for Injection Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Azacitidine for Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Azacitidine for Injection, Product Type & Application
2.7 Azacitidine for Injection Market Competitive Situation and Trends
2.7.1 Azacitidine for Injection Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Azacitidine for Injection Players Market Share by Revenue
2.7.3 Global Azacitidine for Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Azacitidine for Injection Retrospective Market Scenario by Region
3.1 Global Azacitidine for Injection Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Azacitidine for Injection Global Azacitidine for Injection Sales by Region: 2018-2029
3.2.1 Global Azacitidine for Injection Sales by Region: 2018-2023
3.2.2 Global Azacitidine for Injection Sales by Region: 2024-2029
3.3 Global Azacitidine for Injection Global Azacitidine for Injection Revenue by Region: 2018-2029
3.3.1 Global Azacitidine for Injection Revenue by Region: 2018-2023
3.3.2 Global Azacitidine for Injection Revenue by Region: 2024-2029
3.4 North America Azacitidine for Injection Market Facts & Figures by Country
3.4.1 North America Azacitidine for Injection Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Azacitidine for Injection Sales by Country (2018-2029)
3.4.3 North America Azacitidine for Injection Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Azacitidine for Injection Market Facts & Figures by Country
3.5.1 Europe Azacitidine for Injection Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Azacitidine for Injection Sales by Country (2018-2029)
3.5.3 Europe Azacitidine for Injection Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Azacitidine for Injection Market Facts & Figures by Country
3.6.1 Asia Pacific Azacitidine for Injection Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Azacitidine for Injection Sales by Country (2018-2029)
3.6.3 Asia Pacific Azacitidine for Injection Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Azacitidine for Injection Market Facts & Figures by Country
3.7.1 Latin America Azacitidine for Injection Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Azacitidine for Injection Sales by Country (2018-2029)
3.7.3 Latin America Azacitidine for Injection Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Azacitidine for Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Azacitidine for Injection Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Azacitidine for Injection Sales by Country (2018-2029)
3.8.3 Middle East and Africa Azacitidine for Injection Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Azacitidine for Injection Sales by Type (2018-2029)
4.1.1 Global Azacitidine for Injection Sales by Type (2018-2023)
4.1.2 Global Azacitidine for Injection Sales by Type (2024-2029)
4.1.3 Global Azacitidine for Injection Sales Market Share by Type (2018-2029)
4.2 Global Azacitidine for Injection Revenue by Type (2018-2029)
4.2.1 Global Azacitidine for Injection Revenue by Type (2018-2023)
4.2.2 Global Azacitidine for Injection Revenue by Type (2024-2029)
4.2.3 Global Azacitidine for Injection Revenue Market Share by Type (2018-2029)
4.3 Global Azacitidine for Injection Price by Type (2018-2029)
5 Segment by Application
5.1 Global Azacitidine for Injection Sales by Application (2018-2029)
5.1.1 Global Azacitidine for Injection Sales by Application (2018-2023)
5.1.2 Global Azacitidine for Injection Sales by Application (2024-2029)
5.1.3 Global Azacitidine for Injection Sales Market Share by Application (2018-2029)
5.2 Global Azacitidine for Injection Revenue by Application (2018-2029)
5.2.1 Global Azacitidine for Injection Revenue by Application (2018-2023)
5.2.2 Global Azacitidine for Injection Revenue by Application (2024-2029)
5.2.3 Global Azacitidine for Injection Revenue Market Share by Application (2018-2029)
5.3 Global Azacitidine for Injection Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Celgene
6.1.1 Celgene Corporation Information
6.1.2 Celgene Description and Business Overview
6.1.3 Celgene Azacitidine for Injection Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Celgene Azacitidine for Injection Product Portfolio
6.1.5 Celgene Recent Developments/Updates
6.2 Meitheal Pharmaceuticals
6.2.1 Meitheal Pharmaceuticals Corporation Information
6.2.2 Meitheal Pharmaceuticals Description and Business Overview
6.2.3 Meitheal Pharmaceuticals Azacitidine for Injection Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Meitheal Pharmaceuticals Azacitidine for Injection Product Portfolio
6.2.5 Meitheal Pharmaceuticals Recent Developments/Updates
6.3 Lupin Limited
6.3.1 Lupin Limited Corporation Information
6.3.2 Lupin Limited Description and Business Overview
6.3.3 Lupin Limited Azacitidine for Injection Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Lupin Limited Azacitidine for Injection Product Portfolio
6.3.5 Lupin Limited Recent Developments/Updates
6.4 Cipla
6.4.1 Cipla Corporation Information
6.4.2 Cipla Description and Business Overview
6.4.3 Cipla Azacitidine for Injection Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Cipla Azacitidine for Injection Product Portfolio
6.4.5 Cipla Recent Developments/Updates
6.5 TEVA
6.5.1 TEVA Corporation Information
6.5.2 TEVA Description and Business Overview
6.5.3 TEVA Azacitidine for Injection Sales, Revenue and Gross Margin (2018-2023)
6.5.4 TEVA Azacitidine for Injection Product Portfolio
6.5.5 TEVA Recent Developments/Updates
6.6 Viatris
6.6.1 Viatris Corporation Information
6.6.2 Viatris Description and Business Overview
6.6.3 Viatris Azacitidine for Injection Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Viatris Azacitidine for Injection Product Portfolio
6.6.5 Viatris Recent Developments/Updates
6.7 Dr. Reddy’s Laboratories
6.6.1 Dr. Reddy’s Laboratories Corporation Information
6.6.2 Dr. Reddy’s Laboratories Description and Business Overview
6.6.3 Dr. Reddy’s Laboratories Azacitidine for Injection Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Dr. Reddy’s Laboratories Azacitidine for Injection Product Portfolio
6.7.5 Dr. Reddy’s Laboratories Recent Developments/Updates
6.8 Amneal Pharmaceuticals
6.8.1 Amneal Pharmaceuticals Corporation Information
6.8.2 Amneal Pharmaceuticals Description and Business Overview
6.8.3 Amneal Pharmaceuticals Azacitidine for Injection Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Amneal Pharmaceuticals Azacitidine for Injection Product Portfolio
6.8.5 Amneal Pharmaceuticals Recent Developments/Updates
6.9 Natco Pharma
6.9.1 Natco Pharma Corporation Information
6.9.2 Natco Pharma Description and Business Overview
6.9.3 Natco Pharma Azacitidine for Injection Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Natco Pharma Azacitidine for Injection Product Portfolio
6.9.5 Natco Pharma Recent Developments/Updates
6.10 Accord Healthcare
6.10.1 Accord Healthcare Corporation Information
6.10.2 Accord Healthcare Description and Business Overview
6.10.3 Accord Healthcare Azacitidine for Injection Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Accord Healthcare Azacitidine for Injection Product Portfolio
6.10.5 Accord Healthcare Recent Developments/Updates
6.11 Shilpa Medicare
6.11.1 Shilpa Medicare Corporation Information
6.11.2 Shilpa Medicare Azacitidine for Injection Description and Business Overview
6.11.3 Shilpa Medicare Azacitidine for Injection Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Shilpa Medicare Azacitidine for Injection Product Portfolio
6.11.5 Shilpa Medicare Recent Developments/Updates
6.12 Chia Tai Tianqing Pharmaceutical
6.12.1 Chia Tai Tianqing Pharmaceutical Corporation Information
6.12.2 Chia Tai Tianqing Pharmaceutical Azacitidine for Injection Description and Business Overview
6.12.3 Chia Tai Tianqing Pharmaceutical Azacitidine for Injection Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Chia Tai Tianqing Pharmaceutical Azacitidine for Injection Product Portfolio
6.12.5 Chia Tai Tianqing Pharmaceutical Recent Developments/Updates
6.13 Jiangsu Hansoh Pharmaceutical
6.13.1 Jiangsu Hansoh Pharmaceutical Corporation Information
6.13.2 Jiangsu Hansoh Pharmaceutical Azacitidine for Injection Description and Business Overview
6.13.3 Jiangsu Hansoh Pharmaceutical Azacitidine for Injection Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Jiangsu Hansoh Pharmaceutical Azacitidine for Injection Product Portfolio
6.13.5 Jiangsu Hansoh Pharmaceutical Recent Developments/Updates
6.14 Sichuan Huiyu Pharmaceutical
6.14.1 Sichuan Huiyu Pharmaceutical Corporation Information
6.14.2 Sichuan Huiyu Pharmaceutical Azacitidine for Injection Description and Business Overview
6.14.3 Sichuan Huiyu Pharmaceutical Azacitidine for Injection Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Sichuan Huiyu Pharmaceutical Azacitidine for Injection Product Portfolio
6.14.5 Sichuan Huiyu Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Azacitidine for Injection Industry Chain Analysis
7.2 Azacitidine for Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Azacitidine for Injection Production Mode & Process
7.4 Azacitidine for Injection Sales and Marketing
7.4.1 Azacitidine for Injection Sales Channels
7.4.2 Azacitidine for Injection Distributors
7.5 Azacitidine for Injection Customers
8 Azacitidine for Injection Market Dynamics
8.1 Azacitidine for Injection Industry Trends
8.2 Azacitidine for Injection Market Drivers
8.3 Azacitidine for Injection Market Challenges
8.4 Azacitidine for Injection Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Tables
Table 1. Global Azacitidine for Injection Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Azacitidine for Injection Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Azacitidine for Injection Market Competitive Situation by Manufacturers in 2022
Table 4. Global Azacitidine for Injection Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Azacitidine for Injection Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Azacitidine for Injection Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Azacitidine for Injection Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Azacitidine for Injection Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Azacitidine for Injection, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Azacitidine for Injection, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Azacitidine for Injection, Product Type & Application
Table 12. Global Key Manufacturers of Azacitidine for Injection, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Azacitidine for Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Azacitidine for Injection as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Azacitidine for Injection Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Azacitidine for Injection Sales by Region (2018-2023) & (K Units)
Table 18. Global Azacitidine for Injection Sales Market Share by Region (2018-2023)
Table 19. Global Azacitidine for Injection Sales by Region (2024-2029) & (K Units)
Table 20. Global Azacitidine for Injection Sales Market Share by Region (2024-2029)
Table 21. Global Azacitidine for Injection Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Azacitidine for Injection Revenue Market Share by Region (2018-2023)
Table 23. Global Azacitidine for Injection Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Azacitidine for Injection Revenue Market Share by Region (2024-2029)
Table 25. North America Azacitidine for Injection Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Azacitidine for Injection Sales by Country (2018-2023) & (K Units)
Table 27. North America Azacitidine for Injection Sales by Country (2024-2029) & (K Units)
Table 28. North America Azacitidine for Injection Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Azacitidine for Injection Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Azacitidine for Injection Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Azacitidine for Injection Sales by Country (2018-2023) & (K Units)
Table 32. Europe Azacitidine for Injection Sales by Country (2024-2029) & (K Units)
Table 33. Europe Azacitidine for Injection Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Azacitidine for Injection Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Azacitidine for Injection Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Azacitidine for Injection Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Azacitidine for Injection Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Azacitidine for Injection Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Azacitidine for Injection Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Azacitidine for Injection Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Azacitidine for Injection Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Azacitidine for Injection Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Azacitidine for Injection Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Azacitidine for Injection Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Azacitidine for Injection Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Azacitidine for Injection Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Azacitidine for Injection Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Azacitidine for Injection Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Azacitidine for Injection Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Azacitidine for Injection Sales (K Units) by Type (2018-2023)
Table 51. Global Azacitidine for Injection Sales (K Units) by Type (2024-2029)
Table 52. Global Azacitidine for Injection Sales Market Share by Type (2018-2023)
Table 53. Global Azacitidine for Injection Sales Market Share by Type (2024-2029)
Table 54. Global Azacitidine for Injection Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Azacitidine for Injection Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Azacitidine for Injection Revenue Market Share by Type (2018-2023)
Table 57. Global Azacitidine for Injection Revenue Market Share by Type (2024-2029)
Table 58. Global Azacitidine for Injection Price (US$/Unit) by Type (2018-2023)
Table 59. Global Azacitidine for Injection Price (US$/Unit) by Type (2024-2029)
Table 60. Global Azacitidine for Injection Sales (K Units) by Application (2018-2023)
Table 61. Global Azacitidine for Injection Sales (K Units) by Application (2024-2029)
Table 62. Global Azacitidine for Injection Sales Market Share by Application (2018-2023)
Table 63. Global Azacitidine for Injection Sales Market Share by Application (2024-2029)
Table 64. Global Azacitidine for Injection Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Azacitidine for Injection Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Azacitidine for Injection Revenue Market Share by Application (2018-2023)
Table 67. Global Azacitidine for Injection Revenue Market Share by Application (2024-2029)
Table 68. Global Azacitidine for Injection Price (US$/Unit) by Application (2018-2023)
Table 69. Global Azacitidine for Injection Price (US$/Unit) by Application (2024-2029)
Table 70. Celgene Corporation Information
Table 71. Celgene Description and Business Overview
Table 72. Celgene Azacitidine for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. Celgene Azacitidine for Injection Product
Table 74. Celgene Recent Developments/Updates
Table 75. Meitheal Pharmaceuticals Corporation Information
Table 76. Meitheal Pharmaceuticals Description and Business Overview
Table 77. Meitheal Pharmaceuticals Azacitidine for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. Meitheal Pharmaceuticals Azacitidine for Injection Product
Table 79. Meitheal Pharmaceuticals Recent Developments/Updates
Table 80. Lupin Limited Corporation Information
Table 81. Lupin Limited Description and Business Overview
Table 82. Lupin Limited Azacitidine for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Lupin Limited Azacitidine for Injection Product
Table 84. Lupin Limited Recent Developments/Updates
Table 85. Cipla Corporation Information
Table 86. Cipla Description and Business Overview
Table 87. Cipla Azacitidine for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Cipla Azacitidine for Injection Product
Table 89. Cipla Recent Developments/Updates
Table 90. TEVA Corporation Information
Table 91. TEVA Description and Business Overview
Table 92. TEVA Azacitidine for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. TEVA Azacitidine for Injection Product
Table 94. TEVA Recent Developments/Updates
Table 95. Viatris Corporation Information
Table 96. Viatris Description and Business Overview
Table 97. Viatris Azacitidine for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Viatris Azacitidine for Injection Product
Table 99. Viatris Recent Developments/Updates
Table 100. Dr. Reddy's Laboratories Corporation Information
Table 101. Dr. Reddy's Laboratories Description and Business Overview
Table 102. Dr. Reddy's Laboratories Azacitidine for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Dr. Reddy's Laboratories Azacitidine for Injection Product
Table 104. Dr. Reddy's Laboratories Recent Developments/Updates
Table 105. Amneal Pharmaceuticals Corporation Information
Table 106. Amneal Pharmaceuticals Description and Business Overview
Table 107. Amneal Pharmaceuticals Azacitidine for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Amneal Pharmaceuticals Azacitidine for Injection Product
Table 109. Amneal Pharmaceuticals Recent Developments/Updates
Table 110. Natco Pharma Corporation Information
Table 111. Natco Pharma Description and Business Overview
Table 112. Natco Pharma Azacitidine for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Natco Pharma Azacitidine for Injection Product
Table 114. Natco Pharma Recent Developments/Updates
Table 115. Accord Healthcare Corporation Information
Table 116. Accord Healthcare Description and Business Overview
Table 117. Accord Healthcare Azacitidine for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Accord Healthcare Azacitidine for Injection Product
Table 119. Accord Healthcare Recent Developments/Updates
Table 120. Shilpa Medicare Corporation Information
Table 121. Shilpa Medicare Description and Business Overview
Table 122. Shilpa Medicare Azacitidine for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. Shilpa Medicare Azacitidine for Injection Product
Table 124. Shilpa Medicare Recent Developments/Updates
Table 125. Chia Tai Tianqing Pharmaceutical Corporation Information
Table 126. Chia Tai Tianqing Pharmaceutical Description and Business Overview
Table 127. Chia Tai Tianqing Pharmaceutical Azacitidine for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. Chia Tai Tianqing Pharmaceutical Azacitidine for Injection Product
Table 129. Chia Tai Tianqing Pharmaceutical Recent Developments/Updates
Table 130. Jiangsu Hansoh Pharmaceutical Corporation Information
Table 131. Jiangsu Hansoh Pharmaceutical Description and Business Overview
Table 132. Jiangsu Hansoh Pharmaceutical Azacitidine for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 133. Jiangsu Hansoh Pharmaceutical Azacitidine for Injection Product
Table 134. Jiangsu Hansoh Pharmaceutical Recent Developments/Updates
Table 135. Sichuan Huiyu Pharmaceutical Corporation Information
Table 136. Sichuan Huiyu Pharmaceutical Description and Business Overview
Table 137. Sichuan Huiyu Pharmaceutical Azacitidine for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 138. Sichuan Huiyu Pharmaceutical Azacitidine for Injection Product
Table 139. Sichuan Huiyu Pharmaceutical Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Azacitidine for Injection Distributors List
Table 143. Azacitidine for Injection Customers List
Table 144. Azacitidine for Injection Market Trends
Table 145. Azacitidine for Injection Market Drivers
Table 146. Azacitidine for Injection Market Challenges
Table 147. Azacitidine for Injection Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Azacitidine for Injection
Figure 2. Global Azacitidine for Injection Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Azacitidine for Injection Market Share by Type in 2022 & 2029
Figure 4. Original Drug Product Picture
Figure 5. Generic Drug Product Picture
Figure 6. Global Azacitidine for Injection Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Azacitidine for Injection Market Share by Application in 2022 & 2029
Figure 8. Hospitals
Figure 9. Clinics
Figure 10. Others
Figure 11. Global Azacitidine for Injection Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Azacitidine for Injection Market Size (2018-2029) & (US$ Million)
Figure 13. Global Azacitidine for Injection Sales (2018-2029) & (K Units)
Figure 14. Global Azacitidine for Injection Average Price (US$/Unit) & (2018-2029)
Figure 15. Azacitidine for Injection Report Years Considered
Figure 16. Azacitidine for Injection Sales Share by Manufacturers in 2022
Figure 17. Global Azacitidine for Injection Revenue Share by Manufacturers in 2022
Figure 18. The Global 5 and 10 Largest Azacitidine for Injection Players: Market Share by Revenue in 2022
Figure 19. Azacitidine for Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 20. Global Azacitidine for Injection Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 21. North America Azacitidine for Injection Sales Market Share by Country (2018-2029)
Figure 22. North America Azacitidine for Injection Revenue Market Share by Country (2018-2029)
Figure 23. United States Azacitidine for Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Canada Azacitidine for Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Europe Azacitidine for Injection Sales Market Share by Country (2018-2029)
Figure 26. Europe Azacitidine for Injection Revenue Market Share by Country (2018-2029)
Figure 27. Germany Azacitidine for Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. France Azacitidine for Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. U.K. Azacitidine for Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Italy Azacitidine for Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Russia Azacitidine for Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Asia Pacific Azacitidine for Injection Sales Market Share by Region (2018-2029)
Figure 33. Asia Pacific Azacitidine for Injection Revenue Market Share by Region (2018-2029)
Figure 34. China Azacitidine for Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Japan Azacitidine for Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. South Korea Azacitidine for Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. India Azacitidine for Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Australia Azacitidine for Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. China Taiwan Azacitidine for Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Indonesia Azacitidine for Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Thailand Azacitidine for Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Malaysia Azacitidine for Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Latin America Azacitidine for Injection Sales Market Share by Country (2018-2029)
Figure 44. Latin America Azacitidine for Injection Revenue Market Share by Country (2018-2029)
Figure 45. Mexico Azacitidine for Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Brazil Azacitidine for Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Argentina Azacitidine for Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Middle East & Africa Azacitidine for Injection Sales Market Share by Country (2018-2029)
Figure 49. Middle East & Africa Azacitidine for Injection Revenue Market Share by Country (2018-2029)
Figure 50. Turkey Azacitidine for Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Saudi Arabia Azacitidine for Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. UAE Azacitidine for Injection Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Global Sales Market Share of Azacitidine for Injection by Type (2018-2029)
Figure 54. Global Revenue Market Share of Azacitidine for Injection by Type (2018-2029)
Figure 55. Global Azacitidine for Injection Price (US$/Unit) by Type (2018-2029)
Figure 56. Global Sales Market Share of Azacitidine for Injection by Application (2018-2029)
Figure 57. Global Revenue Market Share of Azacitidine for Injection by Application (2018-2029)
Figure 58. Global Azacitidine for Injection Price (US$/Unit) by Application (2018-2029)
Figure 59. Azacitidine for Injection Value Chain
Figure 60. Azacitidine for Injection Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • イソニアジド注射液のグローバル市場展望 2023年-2029年：ジェネリック医薬品、先発医薬品
  • テノフォビルアラフェナミドフマル酸塩錠剤のグローバル市場展望 2023年-2029年：先発医薬品、ジェネリック医薬品
  • ニンテダニブエシレートソフトカプセルのグローバル市場展望 2023年-2029年：先発医薬品、ジェネリック医薬品
  • リン酸テディゾリド錠のグローバル市場展望 2023年-2029年：先発医薬品、ジェネリック医薬品
  • アピキサバン錠のグローバル市場展望 2023年-2029年：先発医薬品、ジェネリック医薬品
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA8686 )"注射用アザシチジンの世界市場2023年：先発医薬品、ジェネリック医薬品" (英文：Global Azacitidine for Injection Market Research Report 2023)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。